Sandoz digital “Scientific Standalone” event will help drive access to medical information in field of cardiovascular therapies
Mar 20, 2017
Sandoz Scientific Standalone event -- “Reach Targets, Save Lives” – aims at increasing access to information in the field of cardiovascular therapies in Central & Eastern Europe and Middle East & Africa (CEEMEA)
Lectures by leading cardiologists and internal medicine specialists will be recorded and offered for re-use across the region following the live event
Enhanced digital training can help improve health outcomes for patients
Holzkirchen, March 20, 2017– Sandoz is organizing a first-of-a-kind “digital” event -- “Reach Targets, Save Lives” -- on March 21, in Warsaw, Poland. This event aims to increase access to valuable medical information in the field of cardiovascular therapies for healthcare professionals across the CEEMEA region.
Speaking ahead of the event, Francesco Balestrieri, Head of Sandoz CEEMEA, said: “Our goal at Sandoz is to increase access to high-quality medicines, medical information and medical capacity for millions of people every year. To achieve this, we are constantly looking for new and innovative ways to engage with the medical community.”
He added: “This event, the first such organized by Sandoz in the CEEMEA region, is testimony to our commitment to make medical information available to as many specialists as possible. We fundamentally believe that health outcomes for patients can be improved if more people are better trained to prevent, diagnose and treat diseases appropriately.”
Cardiovascular diseases are commonly recognized as a leading cause of death worldwide in recent decades *1-4. There are many reasons for such alarming statistics, but two common denominators. One important group is undiagnosed and untreated patients; the other is treated, but ineffectively controlled patients. Both groups are failing to reach target values that are safer for them, especially long-term. To address these two major reasons for cardiovascular mortality, Sandoz, in collaboration with local medical doctors’ communities from CEEMEA countries, has chosen four focus topics for the event:
Chronic kidney disease
The “Reach Targets, Save Lives” event will be organized on-site in Warsaw and broadcast to more than 20 countries in the CEEMEA region simultaneously. Local KOLs participating at these locations are then encouraged to share the content further at local events.
Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2016 sales of USD 10.1 billion. In 2016, our products reached well over 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.